#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	179	13870	16S	1529	1529	100.0	16S.l6.c30.ctg.1	2136	761.1	1	SNP	n	C1184T	0	.	.	1184	1184	C	1354	1354	C	862	C,A	861,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	179	13870	16S	1529	1529	100.0	16S.l6.c30.ctg.1	2136	761.1	0	HET	.	.	.	G1207A,T	.	1207	1207	G	1377	1377	G	862	G,A,T	683,178,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	23014	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3923	730.4	0	.	n	.	0	T695C	SNP	695	695	T	1237	1237	C	854	C,A,G	850,3,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	23014	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3923	730.4	0	.	n	.	0	G1337A	SNP	1337	1337	G	1879	1879	A	938	A,T	937,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	23014	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3923	730.4	0	.	n	.	0	T1971C	SNP	1971	1971	T	2513	2513	C	768	C,T,A	766,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	23014	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3923	730.4	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	3139	3139	T	812	T,C,G,A	594,216,1,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	23014	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3923	730.4	1	SNP	n	A2045G	0	.	.	2045	2045	A	2587	2587	A	698	A,G,C	696,1,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1506	folP	858	858	91.61	folP.l15.c4.ctg.1	2011	93.2	0	.	p	.	0	V36A	NONSYN	106	108	GTG	632	634	GCG	179;176;177	G;C;G	179;176;177	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1506	folP	858	858	91.61	folP.l15.c4.ctg.1	2011	93.2	0	.	p	.	0	Q50R	NONSYN	148	150	CAG	674	676	CGG	199;197;197	C;G;G	198;196;196	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1506	folP	858	858	91.61	folP.l15.c4.ctg.1	2011	93.2	0	.	p	.	0	S68L	NONSYN	202	204	TCG	728	730	TTG	150;148;147	T;T;G	150;148;147	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1506	folP	858	858	91.61	folP.l15.c4.ctg.1	2011	93.2	0	.	p	.	0	A90V	NONSYN	268	270	GCG	794	796	GTT	116;114;111	G,T;T;T	115,1;114;111	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1506	folP	858	858	91.61	folP.l15.c4.ctg.1	2011	93.2	0	.	p	.	0	I105V	NONSYN	313	315	ATT	839	841	GTT	121;121;119	G;T;T	121;121;119	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1506	folP	858	858	91.61	folP.l15.c4.ctg.1	2011	93.2	0	.	p	.	0	N125T	NONSYN	373	375	AAT	899	901	ACC	167;166;168	A;C;C	167;166;168	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1506	folP	858	858	91.61	folP.l15.c4.ctg.1	2011	93.2	0	.	p	.	0	R135C	NONSYN	403	405	CGT	929	931	TGT	181;180;178	T,C,A;G;T,G	179,1,1;180;177,1	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1506	folP	858	858	91.61	folP.l15.c4.ctg.1	2011	93.2	0	.	p	.	0	K151E	NONSYN	451	453	AAA	977	979	GAA	173;171;171	G;A;A	173;171;171	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1506	folP	858	858	91.61	folP.l15.c4.ctg.1	2011	93.2	0	.	p	.	0	T152N	NONSYN	454	456	ACC	980	982	AAC	170;172;173	A,G;A;C	169,1;172;173	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1506	folP	858	858	91.61	folP.l15.c4.ctg.1	2011	93.2	0	.	p	.	0	A172T	NONSYN	514	516	GCG	1040	1042	ACA	158;157;157	A;C;A	158;157;157	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1506	folP	858	858	91.61	folP.l15.c4.ctg.1	2011	93.2	0	.	p	.	0	A175E	NONSYN	523	525	GCG	1049	1051	GAA	159;160;162	G,C;A;A,C	158,1;160;161,1	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1506	folP	858	858	91.61	folP.l15.c4.ctg.1	2011	93.2	0	.	p	.	0	E176T	NONSYN	526	528	GAA	1052	1054	ACC	161;158;159	A,C;C;C	159,2;158;159	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1506	folP	858	858	91.61	folP.l15.c4.ctg.1	2011	93.2	0	.	p	.	0	I178V	NONSYN	532	534	ATC	1058	1060	GTC	164;163;164	G;T,C,G;C	164;161,1,1;164	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1506	folP	858	858	91.61	folP.l15.c4.ctg.1	2011	93.2	0	.	p	.	0	I188T	NONSYN	562	564	ATA	1088	1090	ACG	178;173;173	A;C;G	178;173;173	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1506	folP	858	858	91.61	folP.l15.c4.ctg.1	2011	93.2	0	.	p	.	0	P200N	NONSYN	598	600	CCC	1124	1126	AAC	140;139;138	A;A,C;C	140;138,1;138	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1506	folP	858	858	91.61	folP.l15.c4.ctg.1	2011	93.2	0	.	p	.	0	F220L	NONSYN	658	660	TTT	1184	1186	TTG	119;117;115	T;T;G	119;117;115	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1506	folP	858	858	91.61	folP.l15.c4.ctg.1	2011	93.2	0	.	p	.	0	A239T	NONSYN	715	717	GCA	1241	1243	ACC	117;117;117	A;C;C	117;117;117	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1506	folP	858	858	91.61	folP.l15.c4.ctg.1	2011	93.2	0	.	p	.	0	N240D	NONSYN	718	720	AAT	1244	1246	GAC	119;119;123	G;A;C	119;119;123	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1506	folP	858	858	91.61	folP.l15.c4.ctg.1	2011	93.2	0	.	p	.	0	E243A	NONSYN	727	729	GAA	1253	1255	GCG	126;126;129	G;C;G	126;126;129	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1506	folP	858	858	91.61	folP.l15.c4.ctg.1	2011	93.2	0	.	p	.	0	S255A	NONSYN	763	765	TCC	1289	1291	GCT	138;138;139	G;C,T;T	138;137,1;139	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1506	folP	858	858	91.61	folP.l15.c4.ctg.1	2011	93.2	1	SNP	p	R230S	1	.	.	688	690	AGC	1214	1216	AGC	99;99;100	A;G;C	99;99;100	folP.Neisseria_meningitidis_MC58_v2_01707:1:1:R230S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5044	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3919	160.4	1	SNP	p	S91F	0	.	.	271	273	TCC	784	786	TCC	219;217;217	T;C;C,G	219;217;216,1	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5044	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3919	160.4	1	SNP	p	D95G	0	.	.	283	285	GAC	796	798	GAC	228;231;231	G;A,T,C;C	228;229,1,1;231	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5044	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3919	160.4	1	SNP	p	D95N	0	.	.	283	285	GAC	796	798	GAC	228;231;231	G;A,T,C;C	228;229,1,1;231	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_L_00489c	mtrR.WHO_L_00489c	1	1	27	2016	mtrR	633	633	100.0	mtrR.l6.c4.ctg.1	1774	141.9	1	SNP	p	G45D	1	.	.	133	135	GAC	703	705	GAC	235;234;237	G,A;A;C	234,1;234;237	mtrR.WHO_L_00489c:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	1120	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1481	94.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4930	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3411	180.1	1	SNP	p	D86N	0	.	.	256	258	GAC	831	833	GAC	221;218;217	G;A;C	221;218;217	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4930	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3411	180.1	1	SNP	p	S87R	0	.	.	259	261	AGT	834	836	AGT	214;217;217	A;G;T	214;217;217	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4930	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3411	180.1	1	SNP	p	S87W	0	.	.	259	261	AGT	834	836	AGT	214;217;217	A;G;T	214;217;217	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4930	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3411	180.1	1	SNP	p	S87I	0	.	.	259	261	AGT	834	836	AGT	214;217;217	A;G;T	214;217;217	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4930	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3411	180.1	1	SNP	p	S88P	0	.	.	262	264	TCC	837	839	TCC	218;217;215	T;C;C,A	218;217;214,1	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4210	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3159	166.2	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1813	1815	GGC	220;222;218	G,C;G;C	219,1;222;218	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	3816	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2844	167.3	1	SNP	p	A311V	0	.	.	931	933	GCA	1452	1454	GCA	214;211;209	G;C;A	214;211;209	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3816	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2844	167.3	1	SNP	p	I312M	0	.	.	934	936	ATC	1455	1457	ATC	210;210;210	A;T;C	210;210;210	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3816	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2844	167.3	1	SNP	p	V316T	0	.	.	946	948	GTG	1467	1469	GTG	208;211;213	G;T;G,T	208;211;211,2	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3816	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2844	167.3	1	SNP	p	V316P	0	.	.	946	948	GTG	1467	1469	GTG	208;211;213	G;T;G,T	208;211;211,2	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3816	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2844	167.3	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1971	1973	ACC	219;219;217	A,T;C,T;C,T	218,1;218,1;216,1	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3816	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2844	167.3	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2025	2027	GCG	210;209;209	G;C,G;G	210;208,1;209	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3816	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2844	167.3	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2025	2027	GCG	210;209;209	G;C,G;G	210;208,1;209	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3816	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2844	167.3	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2148	2150	GGC	227;228;226	G;G,T;C	227;227,1;226	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3816	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2844	167.3	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2157	2159	GGC	220;222;221	G;G;C	220;222;221	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3816	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2844	167.3	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2175	2177	CCG	224;224;221	C;C;G	224;224;221	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5268	ponA	2397	2397	99.96	ponA.l15.c17.ctg.1	3550	185.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2354	porA	1146	1146	99.83	porA.l15.c4.ctg.1	2293	127.9	0	.	p	.	0	M83fs	FSHIFT	247	247	A	764	764	C	180	C	180	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	294	porB1a	984	287	90.72	porB1a.l15.c30.ctg.1	905	25.4	0	.	p	.	0	H217N	NONSYN	649	651	CAT	640	642	AAT	8;7;8	A;A;T	8;7;8	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	294	porB1a	984	287	90.72	porB1a.l15.c30.ctg.1	905	25.4	0	.	p	.	0	D218N	NONSYN	652	654	GAT	643	645	AAT	8;8;8	A;A;T	8;8;8	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	294	porB1a	984	287	90.72	porB1a.l15.c30.ctg.1	905	25.4	0	.	p	.	0	A222V	NONSYN	664	666	GCT	655	657	GTT	9;9;9	G;T;T	9;9;9	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	294	porB1a	984	287	90.72	porB1a.l15.c30.ctg.1	905	25.4	0	.	p	.	0	V226A	NONSYN	676	678	GTA	667	669	GCA	7;7;7	G;C;A	7;7;7	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	294	porB1a	984	287	90.72	porB1a.l15.c30.ctg.1	905	25.4	0	.	p	.	0	.	MULTIPLE	700	702	ACT	690	692	GTA	7;7;7	G;T;A	7;7;7	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	294	porB1a	984	287	90.72	porB1a.l15.c30.ctg.1	905	25.4	0	.	p	.	0	N237fs	FSHIFT	709	709	A	699	699	A	7	A	7	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2626	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1727	189.3	0	.	p	.	0	G38E	NONSYN	112	114	GGA	622	624	GAA	237;239;238	G;A;A	237;239;238	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2626	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1727	189.3	0	.	p	.	0	S46G	NONSYN	136	138	AGC	646	648	GGC	255;256;256	G;G;C	255;256;256	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2626	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1727	189.3	0	.	p	.	0	E48G	NONSYN	142	144	GAA	652	654	GGA	257;258;259	G;G,T;A	257;257,1;259	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2626	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1727	189.3	0	.	p	.	0	T87A	NONSYN	259	261	ACT	769	771	GCT	215;213;213	G;C;T	215;213;213	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2626	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1727	189.3	0	.	p	.	0	T89S	NONSYN	265	267	ACC	775	777	AGC	215;213;212	A,C;G;C	214,1;213;212	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2626	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1727	189.3	0	.	p	.	0	.	MULTIPLE	358	359	AA	867	868	CG	224;221	C;G	224;221	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2626	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1727	189.3	0	.	p	.	0	.	MULTIPLE	361	362	GA	870	872	CAG	220;221;222	C;A,C;G	220;220,1;222	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2626	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1727	189.3	0	.	p	.	0	N122K	NONSYN	364	366	AAC	874	876	AAA	223;219;220	A,C;A,T;A	222,1;218,1;220	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2626	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1727	189.3	0	.	p	.	0	K143E	NONSYN	427	429	AAA	937	939	GAA	230;231;232	G;A,C;A,C	230;230,1;231,1	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2626	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1727	189.3	0	.	p	.	0	V151A	NONSYN	451	453	GTA	961	963	GCA	237;238;238	G;C;A	237;238;238	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2626	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1727	189.3	0	.	p	.	0	A215T	NONSYN	643	645	GCT	1153	1155	ACT	190;189;190	A;C;T	190;189;190	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2626	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1727	189.3	0	.	p	.	0	I218M	NONSYN	652	654	ATA	1162	1164	ATG	199;200;199	A;T;G,A	199;200;198,1	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2626	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1727	189.3	0	.	p	.	0	T256A	NONSYN	766	768	ACA	1276	1278	GCA	222;220;220	G;C;A	222;220;220	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2626	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1727	189.3	0	.	p	.	0	W257T	NONSYN	769	771	TGG	1279	1281	ACG	219;219;220	A,C;C;G	218,1;219;220	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2626	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1727	189.3	0	.	p	.	0	S258G	NONSYN	772	774	AGT	1282	1284	GGG	219;219;222	G;G;G	219;219;222	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2626	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1727	189.3	0	.	p	.	0	A259V	NONSYN	775	777	GCT	1285	1287	GTT	219;217;217	G;T;T	219;217;217	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2626	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1727	189.3	0	.	p	.	0	L279V	NONSYN	835	837	TTA	1345	1347	GTA	228;226;228	G;T,C;A,G,C	228;225,1;226,1,1	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2626	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1727	189.3	0	.	p	.	0	S292T	NONSYN	874	876	TCT	1384	1386	ACT	212;210;209	A,C;C;T	211,1;210;209	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2626	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1727	189.3	0	.	p	.	0	H294D	NONSYN	880	882	CAT	1390	1392	GAT	213;214;216	G;A,C;T	213;213,1;216	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2626	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1727	189.3	0	.	p	.	0	Y298H	NONSYN	892	894	TAC	1402	1404	CAC	227;226;225	C,G;A,C;C,A	226,1;225,1;224,1	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2626	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1727	189.3	1	SNP	p	G120K	1	.	.	358	360	AAG	867	869	CGG	224;221;219	C;G;G	224;221;219	porB1b.WHO_L_01891c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2626	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1727	189.3	1	SNP	p	D121N	0	.	.	361	363	GAC	870	873	CGC	220;222;223	C;G;C	220;222;223	porB1b.WHO_L_01891c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2626	porB1b	1047	1047	97.04	porB1b.l15.c4.ctg.1	1727	189.3	1	SNP	p	A121D	1	.	.	361	363	GAC	870	873	CGC	220;222;223	C;G;C	220;222;223	porB1b.WHO_L_01891c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	9298	rpoB	4179	4179	100.0	rpoB.l6.c17.ctg.1	5259	220.6	1	SNP	p	H553N	0	.	.	1657	1659	CAT	2215	2217	CAT	224;227;227	C,G;A,T;T,C	223,1;226,1;226,1	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1350	rpsJ	312	312	100.0	rpsJ.l6.c4.ctg.1	1434	117.1	1	SNP	p	V57M	1	.	.	169	171	ATG	712	714	ATG	241;242;241	A;T;G,T	241;242;240,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
